Publications by authors named "Raymond J Winquist"

Claim this Profile
I
Inhibiting Cytosine-Adenine-Guanine (CAG) repeat expansions as a therapeutic strategy for Huntington's disease.
Raymond J Winquist, Bruce Church

Biochem Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potassium channelopathies associated with epilepsy-related syndromes and directions for therapeutic intervention.
Valentin K Gribkoff, Raymond J Winquist

Biochem Pharmacol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer.
Yuanwang Pan, Yuan Hao, Han Han, Ting Chen, Hailin Ding, Raymond J Winquist

J Immunother Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular effects of GLP-1 receptor agonism.
Raymond J Winquist, Valentin K Gribkoff

Adv Pharmacol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting putative components of the mitochondrial permeability transition pore for novel therapeutics.
Raymond J Winquist, Valentin K Gribkoff

Biochem Pharmacol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of biological/pathophysiological contexts to help clarify genotype-phenotype mismatches in monogenetic diseases. Childhood epilepsies associated with SCN2A as a case study.
Raymond J Winquist, Charles J Cohen

Biochem Pharmacol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases.
Luc J Farmer, Mark W Ledeboer, Thomas Hoock, Michael J Arnost, Randy S Bethiel, Raymond J Winquist

J Med Chem· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the immortal strand hypothesis in cancer stem cells: symmetric/self-renewal as the relevant surrogate marker of tumorigenicity.
Raymond J Winquist, Amy B Hall, Brenda K Eustace, Brinley F Furey

Biochem Pharmacol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The fall and rise of pharmacology--(re-)defining the discipline?
Raymond J Winquist, Kevin Mullane, Michael Williams

Biochem Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational paradigms in pharmacology and drug discovery.
Kevin Mullane, Raymond J Winquist, Michael Williams

Biochem Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replicated, replicable and relevant-target engagement and pharmacological experimentation in the 21st century.
Terry Kenakin, David B Bylund, Myron L Toews, Kevin Mullane, Raymond J Winquist

Biochem Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Island biogeography effects on microbial evolution may contribute to Crohn's disease.
Mac A Johnson, Raymond J Winquist

Biochem Pharmacol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer stem cells as the relevant biomass for drug discovery.
Raymond J Winquist, Brinley F Furey, Diane M Boucher

Curr Opin Pharmacol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing development of new therapeutics for oncology.
Raymond J Winquist, Diane M Boucher

Curr Opin Pharmacol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.
Raymond J Winquist, Diane M Boucher, Mark Wood, Brinley F Furey

Biochem Pharmacol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The complex etiology of multiple sclerosis.
Raymond J Winquist, Ann Kwong, Ravi Ramachandran, Jugnu Jain

Biochem Pharmacol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use-dependent blockade of Cav2.2 voltage-gated calcium channels for neuropathic pain.
Raymond J Winquist, Jennifer Qian Pan, Valentin K Gribkoff

Biochem Pharmacol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voltage-gated cation channel modulators for the treatment of stroke.
Valentin K Gribkoff, Raymond J Winquist

Expert Opin Investig Drugs· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis